Good to see positive momentum, albeit not sure it warranted a guidance update. Sure 23% improvement, but already forecasting first EBITDA positive year which was significant enough IMO. Feels like CCR is a momentum business, with well explained lag times between onboarding and revenue growth. Probably more to come given macro tailwinds, recent sales success, and business unit integration hopefully stabilising. Valuation is understandable in this environment, and remains a courage hold, but further revenue growth is key for market to be convinced.
Ann: Further upgrade to FY24 Guidance, page-8
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CCR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.025(9.09%) |
Mkt cap ! $125.3M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 30.0¢ | 28.0¢ | $60.12K | 209.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40000 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 84946 | 2 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| CCR (ASX) Chart |